Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Vaxart Inc. (VXRT)

7.98   -0.21 (-2.56%) 07-10 16:00
Open: 8.05 Pre. Close: 8.19
High: 8.15 Low: 7.61
Volume: 10,170,295 Market Cap: 758M
Vaxart, Inc., a clinical-stage company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus. It is also developing therapeutic immune-oncology vaccines for cervical cancer and dysplasia caused by human papillomavirus. Vaxart, Inc. has a research collaboration agreement with Janssen Vaccines & Prevention B.V. (Janssen) to evaluate the company's proprietary oral vaccine platform for the Janssen universal influenza vaccine program. The company is headquartered in South San Francisco, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 8.169 - 8.209 8.209 - 8.242
Low: 7.503 - 7.556 7.556 - 7.598
Close: 7.904 - 7.986 7.986 - 8.053

Technical analysis

as of: 2020-07-10 4:33:26 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 11.32     One year: 16.70
Support: Support1: 2.23    Support2: 1.86
Resistance: Resistance1: 9.69    Resistance2: 14.30
Pivot: 6.45
Moving Average: MA(5): 7.93     MA(20): 5.45
MA(100): 2.92     MA(250): 1.48
MACD: MACD(12,26): 1.46     Signal(9): 1.24
Stochastic oscillator: %K(14,3): 47.91     %D(3): 48.16
RSI: RSI(14): 64.96
52-week: High: 14.30  Low: 0.25  Change(%): 1008.3
Average Vol(K): 3-Month: 1843698  10-Days: 5831333

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
VXRT has closed below upper band by 33.5%. Bollinger Bands are 345.5% wider than normal. The large width of the bands suggest high volatility as compared to VXRT's normal range. The bands have been in this wide range for 10 bars. This is a sign that the current trend might continue.

Headline News

Thu, 09 Jul 2020
Is Vaxart Stock a Buy? - Motley Fool

Wed, 08 Jul 2020
Better Coronavirus Stock: Altimmune vs. Vaxart - Motley Fool

Tue, 07 Jul 2020
Buy or Sell Vaxart, Inc. (VXRT) Stock Now? Don't Try to Be a Top Gun - The News Heater

Tue, 07 Jul 2020
Better Coronavirus Stock: VBI Vaccines or Vaxart? - Motley Fool

Mon, 06 Jul 2020
Vaxart Inc. (VXRT) is primed for evolution with the beta value of 0.32 - The InvestChronicle

Thu, 02 Jul 2020
Is Vaxart Inc (VXRT) Stock a Good Buy on Thursday? - InvestorsObserver

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 74
Shares Float (M) 59
% Held by Insiders 1.21
% Held by Institutions 36.23
Shares Short (K) 4,090
Shares Short P. Month (K) 1,990

Stock Financials

EPS -0.530
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.440
Profit Margin -252.86
Operating Margin -150.16
Return on Assets (ttm) -15.5
Return on Equity (ttm) -84.8
Qtrly Rev. Growth -46.3
Gross Profit (p.s.) -0.063
Sales Per Share 0.099
EBITDA (p.s.) -0.107
Qtrly Earnings Growth
Operating Cash Flow (M) -12
Levered Free Cash Flow (M) -2

Stock Valuations

PE Ratio -15.06
PEG Ratio
Price to Book value 18.14
Price to Sales 80.43
Price to Cash Flow -50.86

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date 2012-11-08
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.